We have demonstrated that basophils can be identified within whole blood samples taken from cancer patients and can be activated ex vivo to upregulate cell surface CD63 with IgE-mediated (anti-FcεRI, anti-IgE) and with innate (fMLP) stimuli [28,96,97]. This evidence concerns the gene CD63 and cancer.